Furthermore, IL-1α induces osteoclast function and increases bone matrix degradation [51], and it is known that MMP-2 and MMP-9 also cause bone matrix degradation for patients with cholesteatoma [36,37]. Here, MMP2 is linked to cholesteatoma.